4th Quarter - Report

WINNING STRATEGIES WASHINGTON for DIABETES PATIENT ADVOCACY COALITION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$10,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Jan 19, 2023 $10,000 Replaced
4th Quarter - Amendment Jan 20, 2023 $10,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to treatment of diabetes and support for diabetes patients; insulin affordability legislation; legislation related to pharmacy benefit managers

LobbyistCovered position, as disclosed
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
JARED RYAN SUTTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Issues related to treatment of diabetes and obesity and support for diabetes patients

LobbyistCovered position, as disclosed
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
JARED RYAN SUTTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medical/Disease Research/Clinical Labs MED

Issues related to treatment of diabetes and support for diabetes patients

LobbyistCovered position, as disclosed
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
JARED RYAN SUTTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.